It supports mitochondrial function, promoting energy levels and overall cellular health
The table below organizes what the literature actually shows, with the evidence tier stated explicitly (clinical human data, preclinical lab/animal data, or anecdotal/inferred)
The top dose produced 20.9% average weight loss over 72 weeks and 20.2% in a direct comparison with semaglutides 13.7%. Its second receptor, GIP, separates tirzepatide from approved single-receptor GLP-1 drugs and helps explain the larger population-level weight loss. That 20.9% came from participants averaging about 105 kg at a BMI of 38, most of whom were sedentary
Some people start with weekly injections to restore their levels and then transition to a monthly schedule for maintenance
Methods: This study employed social media listening (SML) to analyze 4,787 relevant posts from X, Reddit, Facebook, blogs, and forums discussing oral medication administration to dogs
All of these effects have been obtained within experimental models